A Phase 3 Prospective, Randomized, Double-blinded, Placebo-controlled Clinical Study to Evaluate the Efficacy and safety of Rebiotix RBX2660 (microbiota suspension) for the Prevention of Recurrent Clostridium difficile Infection
Administered By
Awarded By
Contributors
- Barto, Amy Elizabeth Principal Investigator
Start/End
- June 19, 2019 - November 19, 2021